Thomas Bures
CIK 1787029 · Chief Accounting Officer · last filed 2026-02-18
Thomas Bures is a Chief Accounting Officer who has filed 7 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing shows the insider had shares withheld for taxes covering $10.0K of BRKRP on Feb 18, 2026. Across all open-market trades the lifetime net is +$23.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.47M
3
7
$23.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BRKRP | Chief Accounting Officer | 3,198 | $401.31 | $1.28M | $0 | 1 | 2026-02-18 |
| BRKR | Chief Accounting Officer | 3,472 | $54.23 | $188.3K | $23.7K | 2 | 2025-03-11 |
| PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Chief Financial Officer | — | $13.60 | — | $0 | 4 | 2023-02-28 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-18 | BRKRP | Tax (F) | −274 | -$10.0K | EDGAR |
| 2025-03-11 | BRKR | Buy (P) | +500 | $23.7K | EDGAR |
| 2025-02-19 | BRKR | Grant (A) | +2,972 | $0 | EDGAR |
| 2023-02-28 | PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-24 | PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-08 | PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-02 | PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Grant (A) | — | $0 | EDGAR |